K-ras mutation detected in blood as a predictive factor in patients with recurrent prostate cancer
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Poster
- By: KOLESAR, Jill (University of Wisconsin, Madison, United States of America)
- Co-author(s): Teng, Jian (University of Wisconsin, MADISON, United States of America)
Riley, Brian (University of Wisconsin, MADISON, United States of America)
Background: K-ras mutations occur in approximately 10% of prostate cancers, but little is known about K-ras status in the somatic DNA. The aim of this study was to determine the frequency and concordance of K-ras mutations in the peripheral blood and prostate tumor tissue.
Patients and Methods: K-ras mutations in codon 12, 13, and 61 were.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.